MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Abbott, Medtronic Battle Over Patent

FDA News: Abbott has filed a lawsuit against Medtronic for infringing on its patent for the Rapid Exchange system. The lawsuit comes on the heels of Medtronic’s announcement that it is launching its Endeavor drug-eluting stent and other angioplasty products in the U.S. on the Rapid Exchange delivery system, which it anticipates will increase use of its devices, Medtronic says. Abbott says its Xience V drug-eluting stent has rapidly become the U.S. market leader.

It does not expect MedtronicâEUR(TM)s launch of a new delivery system to change market dynamics.

Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish